As of August 28, 2026, Summit Therapeutics Inc. (SMMT) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Summit Therapeutics Inc. has a market capitalization of $13.61B, 797.75M shares outstanding. Stored dilution-related fields include 3.36M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SMMT.
Market Data
Market Cap$13.61B
Shares Outstanding797.75M
Float134.66M
Cash$690.68M
Debt$20.04M
Short InterestN/A
Institutional Holdings
15.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest36.25M
Days to Cover8.9
% of Float26.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual SMMT Dilution Snapshot
Summit Therapeutics Inc. (SMMT) has a DilutionScore of 21/100, rated Low dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 3.4M.
- Recent SEC activity tracked for SMMT: xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track SMMT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SMMT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for SMMT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.